Paul Gilman

Headshot of Paul Gilman

Resident Faculty

Professor

Dr. Gilman is the Director of the Clinical Research Center at LIMR.

Contact Us

Call 484.476.4837
gilmanp@mlhs.org
View Google Scholar to learn more

About

  • Director, Clinical Research Center
  • Director, Center for Clinical Cancer Research

Publications

  • Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial. Weiss M, Giaddui M, Kjelstrom S, … Burrell J, Diguilio K, Bidas G, Erebor E, Meske S, Saeed L, Windawi S, Ruiz KA, Ghaneie A, Hibbs J, Marks J, Holtz D, Ali Z, Shevade A, Sabol J, Ciocca R, Zeger E, Gilman P, Larson S, et al. Front. Oncol., Sec. Breast Cancer; 2025;15. https://doi.org/10.3389/fonc.2025.1590168
  • A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11. Stearns V, Jegede OA, … Gilman P, et al. Clin Cancer Res. 2024 Apr 19. doi: 10.1158/1078-0432.CCR-23-2137
  • Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292). Kemeny MM, Zhao F, … Gilman PB, et al. Ann Surg Oncol. 2023 Feb;30(2):1099-1109. doi: 10.1245/s10434-022-12705-8
  • A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment. Weiss MC, Hibbs JE, Buckley ME, ... Meske SW, Aliano-Ruiz KE, McHugh TW, Larson SL, … Gilman PB, et al. Cancer. 2022 Jan 1;128(1):160-168.
  • Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial. Mariotti V, … Gilman P, et al. JAMA Oncol. 2021 Jan 1;7(1):61-69.
  • McCourt DD, Parikh K, Brady AL, Wang Y, Kennedy J, Buckley ME, Ali ZA, Shevade AL, Gilman PB, Wallon UM. The quest for reliable prediction of chemotherapy-induced delayed nausea among breast cancer patients. J Unexplored Med Data 2019;4:6.
  • Fox E, Oliver T, Rowe M, Thomas S, Zakharia Y, Gilman PB, Muller AJ, Prendergast GC. Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer. Front Oncol. 2018 Sep 11;8:370.
  • Kutner T, Kunkel E, Wang Y, George K, Zeger EL, Ali ZA, Prendergast GC, Gilman PB, Wallon UM. Preliminary evaluation of a predictive blood assay to identify patients at high risk of chemotherapy-induced nausea. Support Care Cancer 2017 Feb;25(2):581-87.
  • Waks AG, Lennon J, Yadav BS, … Gilman PB, et al. Metastasis to the Cervix Uteri 15 Years After Treatment of Lobular Carcinoma of the Breast. Semin Oncol 2015 Aug;42(4):e81-94.

Education and training

Education

  • MD
    Jefferson Medical College

Academic titles

  • Director, Clinical Research Center
  • Director, Center for Clinical Cancer Research